Home    Back

Pneumococcal polysaccharide vaccine 23 valent    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
265Lipodystrophy1

265. Lipodystrophy    [ 109 clinical trials,   164 drugs,   (DrugBank: 59 drugs),   26 drug target genes,   94 drug target pathways]
Searched query = "Lipodystrophy", "Berardinelli-Seip syndrome", "Lawrence syndrome", "Barraquer-Simons syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 109 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03039491
(ClinicalTrials.gov)		September 1, 201530/1/2017Immune Response to Pneumococcal Vaccination in Aging HIV Positive AdultsImmune Response to Pneumococcal Vaccination in Aging HIV Positive IndividualsHIV Lipodystrophy;AgingBiological: Pneumococcal polysaccharide vaccine 23 valent;Biological: 13 valent conjugated pneumococcal vaccineMedical University of South CarolinaNULLCompleted21 Years65 YearsAll160Early Phase 1United States